NEW YORK (GenomeWeb) – Molecular diagnostics firm Empire Genomics today announced that it has received CE Marking for several of its products including fluorescent in situ hybridization probes and karyotyping media.

Landing the CE Mark "will please our world distributors and will go a long way in accelerating sales in Europe," Empire VP of International Business Development Reza Mazaheri said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.